why choose us

First received: November 05, 2024

Clinical Trial: A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: SARS-CoV-2 Infections

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, OPEN-LABEL, RANDOMIZED, 2-PERIOD, 2-SEQUENCE, CROSSOVER STUDY TO ESTIMATE THE EFFECT OF IBUZATRELVIR ON THE PHARMACOKINETICS OF DABIGATRAN IN HEALTHY ADULT PARTICIPANTS

Brief Summary: This is a Phase 1, open-label, randomized, 2-period, 2-sequence, cross-over study to estimate the effect of ibuzatrelvir on the PK of dabigatran, a P-gp substrate, in healthy adult participants.Participants who discontinue from the study for non-safety reasons may be replaced at the Sponsor's discretion in collaboration with the investigator.Healthy participants will be screened to determine eligibility within 28 days prior to study treatment.Participants will report to the CRU on Period 1 Day -1 in Period 1…

Read more